NCT00617968 GETNA2 Neoadj. TAX+Femara vs Femara in g I/II Breast Cancer Status COMPLETED Phase PHASE2
NCT00617344 Immunogenicity and Safety of Three Formulations of Dengue Vaccines in Healthy Adults Aged 18 to 45 Years in the US Status COMPLETED Phase PHASE2
NCT00616694 Impact of Vertebral Fracture Knowledge on Persistence in Subjects Taking Glucocorticoid Therapy Status COMPLETED Phase PHASE4
NCT00614250 Evaluation of the Effect of AVE0657 on Obstructive Sleep Apnea Status COMPLETED Phase PHASE2
NCT00612677 Pemetrexed &Oxaliplatin in Patients w Recurrent NSCLCa After Failure to Platinum Based Adjuvant Chem Status TERMINATED Phase PHASE2
NCT00611962 Phase II Study of Oxaliplatine-Paclitaxel in Patients With Metastatic Germ Cell Tumor Refractory to Cisplatin Status COMPLETED Phase PHASE2
NCT00611754 Phase II Study of Oxaliplatin in Combination With 5-Fu in 1st Line Treatment of Locally Advanced or Metastatic Squamous Cell Carcinoma of the Head and Neck Status COMPLETED Phase PHASE2
NCT00611507 A Phase II Study of Oxaliplatin in Association With 5FU and Folinic Acid in the Treatment of Subjects With Non-Surgical or Advanced Metastatic Gastric Cancer Status COMPLETED Phase PHASE2
NCT00609895 The Incidence of Hypoglycemia in Insulin Glargine-Treated Subjects With Diabetes Mellitus Upon Switching Between Bedtime and Morning Dosing Status COMPLETED Phase PHASE4
NCT00607087 Effect of Insulin Glulisine Compared to Insulin Aspart and Insulin Lispro When Administered by Continuous Subcutaneous Insulin Infusion (CSII) on Specific Pump Parameters in Patient With Type 1 Diabetes Mellitus Status COMPLETED Phase PHASE4
NCT00604370 Retrospective Study to Review Patients at Risk for VTE at Hospital Discharge Status COMPLETED Phase N/A
NCT00603577 Role of Xaliproden on Recovery Rate From Severe Neuropathy in Patients Who Have Completed Adjuvant Chemotherapy With Oxaliplatin Based Regimens Status TERMINATED Phase PHASE3
NCT00602745 S-1 Versus 5-FU Bolus in Metastatic Pancreatic Cancer Patients Previously Treated With Gemcitabine-Based Regimen Status TERMINATED Phase PHASE3
NCT00602680 Effect on Cognitive Performance and Safety/Tolerability of SSR180711C in Mild Alzheimer's Disease Status TERMINATED Phase PHASE2
NCT00600249 Assessment of the Efficacy of a Neoadjuvant Combination: "Chemotherapy-targeted Therapy" in Breast Cancer. Status COMPLETED Phase PHASE2